Arakawa Chemical Industries, Ltd.

TSE:4968 Stock Report

Market Cap: JP¥21.4b

Arakawa Chemical Industries Balance Sheet Health

Financial Health criteria checks 2/6

Arakawa Chemical Industries has a total shareholder equity of ¥58.6B and total debt of ¥40.0B, which brings its debt-to-equity ratio to 68.2%. Its total assets and total liabilities are ¥122.2B and ¥63.6B respectively.

Key information

68.2%

Debt to equity ratio

JP¥40.01b

Debt

Interest coverage ration/a
CashJP¥11.43b
EquityJP¥58.62b
Total liabilitiesJP¥63.62b
Total assetsJP¥122.24b

Recent financial health updates

Recent updates

Is Arakawa Chemical Industries (TSE:4968) Using Too Much Debt?

Nov 06
Is Arakawa Chemical Industries (TSE:4968) Using Too Much Debt?

Arakawa Chemical Industries' (TSE:4968) Shareholders May Want To Dig Deeper Than Statutory Profit

Aug 09
Arakawa Chemical Industries' (TSE:4968) Shareholders May Want To Dig Deeper Than Statutory Profit

Arakawa Chemical Industries (TSE:4968) Will Pay A Dividend Of ¥24.00

Jul 26
Arakawa Chemical Industries (TSE:4968) Will Pay A Dividend Of ¥24.00

Arakawa Chemical Industries (TSE:4968) Has Announced A Dividend Of ¥24.00

Jul 11
Arakawa Chemical Industries (TSE:4968) Has Announced A Dividend Of ¥24.00

Arakawa Chemical Industries (TSE:4968) Is Paying Out A Dividend Of ¥24.00

Mar 12
Arakawa Chemical Industries (TSE:4968) Is Paying Out A Dividend Of ¥24.00

Arakawa Chemical Industries (TSE:4968) Has Affirmed Its Dividend Of ¥24.00

Feb 27
Arakawa Chemical Industries (TSE:4968) Has Affirmed Its Dividend Of ¥24.00

Financial Position Analysis

Short Term Liabilities: 4968's short term assets (¥61.9B) exceed its short term liabilities (¥40.1B).

Long Term Liabilities: 4968's short term assets (¥61.9B) exceed its long term liabilities (¥23.6B).


Debt to Equity History and Analysis

Debt Level: 4968's net debt to equity ratio (48.7%) is considered high.

Reducing Debt: 4968's debt to equity ratio has increased from 28.8% to 68.2% over the past 5 years.

Debt Coverage: 4968's debt is not well covered by operating cash flow (15.2%).

Interest Coverage: Insufficient data to determine if 4968's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 19:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arakawa Chemical Industries, Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Katsuhiko IshibashiIchiyoshi Research Institute Inc.
Kazumasa FukumotoSMBC Friend Research Centre